| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Purchase of treasury stock | 0 | 0 |
| Lease liability | - | 75,536 |
| Net cash flows provided by financing activities | 4,023,908 | 3,948,372 |
| Net increase (decrease) in cash and cash equivalents | -477,256 | 293,304 |
| Effect of exchange rate changes on cash | 97,165 | - |
| Cash and cash equivalents at end of period | 9,306,438 | - |
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)